Targeting the PD-1 Pathway: A Promising Future for the Treatment of Melanoma

Archives of Dermatological Research - Germany
doi 10.1007/s00403-014-1457-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?

Pancreas - Open Journal
2018English

Immune Modulation Through Targeting PD-1/PDL-1 Signaling Pathway for the Treatment of Osteosarcoma Lung Metastastasis

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Blocking the PD-1/PD-L1 Pathway in Glioma: A Potential New Treatment Strategy

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Targeting the PD-1 Pathway in MSI-Stable Metastatic Colorectal Cancer

Chemotherapy: Open Access
2017English

Targeting the mTOR Pathway Uncouples the Efficacy and Toxicity of PD-1 Blockade in Renal Transplantation

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Vertical Targeting of the Phosphatidylinositol-3 Kinase Pathway as a Strategy for Treating Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Targeting NKT Cells and PD-L1 Pathway Results in Augmented Anti-Tumor Responses in a Melanoma Model

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2011English

Harnessing the PD-1 Pathway in Renal Cell Carcinoma: Current Evidence and Future Directions

BioDrugs
MedicineBiotechnologyPharmacology
2014English

Immunotherapies Based on PD-1/PD-L1 Pathway Inhibitors in Ovarian Cancer Treatment

Clinical and Experimental Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy